1,3,5-trinitro-1,3,5-triazinane decreases expression ISO RGD:1607646 6480464 cyclonite results in decreased expression of MIR200A mRNA CTD PMID:19270793 17beta-estradiol multiple interactions ISO RGD:1348162 6480464 Estradiol results in increased expression of and results in decreased secretion of MIR200A mRNA CTD PMID:33419253 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1348162 6480464 Dihydrotestosterone results in increased expression of MIR200A mRNA CTD PMID:23052036 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1607646 6480464 Tetrachlorodibenzodioxin results in decreased expression of MIR200A mRNA CTD PMID:24154488 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of MIR200A mRNA CTD PMID:19167416 , PMID:22584684 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MIR200A mRNA CTD PMID:24472605 aldehydo-D-glucose decreases expression ISO RGD:1607646 6480464 Glucose results in decreased expression of MIR200A mRNA CTD PMID:23776576 arsane decreases expression ISO RGD:1348162 6480464 Arsenic results in decreased expression of MIR200A mRNA CTD PMID:25586904 arsane multiple interactions ISO RGD:1607646 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MIR200A mRNA CTD PMID:34952004 arsenic atom decreases expression ISO RGD:1348162 6480464 Arsenic results in decreased expression of MIR200A mRNA CTD PMID:25586904 arsenic atom multiple interactions ISO RGD:1607646 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MIR200A mRNA CTD PMID:34952004 benzophenone increases expression EXP 6480464 benzophenone results in increased expression of MIR200A mRNA CTD PMID:22584684 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of MIR200A mRNA CTD PMID:22584684 bisphenol A decreases expression ISO RGD:1607646 6480464 bisphenol A results in decreased expression of MIR200A mRNA CTD PMID:28774890 bisphenol A multiple interactions ISO RGD:1348162 6480464 bisphenol A affects the expression of and affects the secretion of MIR200A mRNA CTD PMID:33419253 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of MIR200A mRNA CTD PMID:25933445 buta-1,3-diene increases expression ISO RGD:1607646 6480464 1, 3-butadiene results in increased expression of MIR200A mRNA CTD PMID:29038090 cadmium dichloride increases expression ISO RGD:1607646 6480464 Cadmium Chloride results in increased expression of MIR200A mRNA CTD PMID:35183672 carbon atom increases expression ISO RGD:1348162 6480464 Carbon results in increased expression of MIR200A mRNA CTD PMID:26068961 carvedilol multiple interactions EXP 6480464 Carvedilol inhibits the reaction [Carbon Tetrachloride results in decreased expression of MIR200A mRNA] CTD PMID:30254303 chlorendic acid increases expression EXP 6480464 chlorendic acid results in increased expression of MIR200A mRNA CTD PMID:22584684 chromium(6+) multiple interactions ISO RGD:1348162 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of MIR200A mRNA CTD PMID:35101437 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of MIR200A mRNA CTD PMID:24880025 D-glucose decreases expression ISO RGD:1607646 6480464 Glucose results in decreased expression of MIR200A mRNA CTD PMID:23776576 dehydroepiandrosterone multiple interactions ISO RGD:1348162 6480464 [Pertussis Toxin co-treated with Dehydroepiandrosterone] results in increased expression of MIR200A mRNA, [wortmannin co-treated with Dehydroepiandrosterone] results in increased expression of MIR200A mRNA CTD PMID:25969534 Diosbulbin B increases expression ISO RGD:1607646 6480464 diosbulbin B results in increased expression of MIR200A mRNA CTD PMID:28844483 dioxygen multiple interactions ISO RGD:1348162 6480464 DICER1 protein inhibits the reaction [Oxygen deficiency results in decreased cleavage of MIR200A mRNA] CTD PMID:25351418 dioxygen decreases expression ISO RGD:1348162 6480464 Oxygen deficiency results in decreased expression of MIR200A mRNA modified form CTD PMID:25351418 dioxygen decreases cleavage ISO RGD:1348162 6480464 Oxygen deficiency results in decreased cleavage of MIR200A mRNA CTD PMID:25351418 elemental carbon increases expression ISO RGD:1348162 6480464 Carbon results in increased expression of MIR200A mRNA CTD PMID:26068961 ethanol decreases expression ISO RGD:1607646 6480464 Ethanol results in decreased expression of MIR200A mRNA CTD PMID:19091803 fenhexamid increases expression ISO RGD:1348162 6480464 N-(2, 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of MIR200A mRNA CTD PMID:23052036 ferulic acid multiple interactions EXP 6480464 ferulic acid inhibits the reaction [Thioacetamide results in decreased expression of MIR200A mRNA] CTD PMID:32278740 fludioxonil increases expression ISO RGD:1348162 6480464 fludioxonil results in increased expression of MIR200A mRNA CTD PMID:23052036 furan increases expression EXP 6480464 furan results in increased expression of MIR200A mRNA CTD PMID:22079235 , PMID:27371368 furan multiple interactions EXP 6480464 furan deficiency inhibits the reaction [furan results in increased expression of MIR200A mRNA] CTD PMID:27371368 gallic acid multiple interactions EXP 6480464 Gallic Acid inhibits the reaction [Thioacetamide results in decreased expression of MIR200A mRNA] CTD PMID:32278740 glucose decreases expression ISO RGD:1607646 6480464 Glucose results in decreased expression of MIR200A mRNA CTD PMID:23776576 hexanal decreases expression EXP 6480464 n-hexanal results in decreased expression of MIR200A mRNA CTD PMID:26403475 icariin increases expression ISO RGD:1607646 6480464 icariin results in increased expression of MIR200A mRNA CTD PMID:30533443 isoprenaline multiple interactions EXP 6480464 Lutein inhibits the reaction [Isoproterenol results in decreased expression of MIR200A mRNA] CTD PMID:34435724 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of MIR200A mRNA CTD PMID:34435724 L-methionine increases expression ISO RGD:1607646 6480464 Methionine deficiency results in increased expression of MIR200A mRNA CTD PMID:35314295 Licochalcone B increases expression ISO RGD:1348162 6480464 licochalcone B results in increased expression of MIR200A mRNA CTD PMID:33647349 lutein multiple interactions EXP 6480464 Lutein inhibits the reaction [Isoproterenol results in decreased expression of MIR200A mRNA] CTD PMID:34435724 mechlorethamine increases expression EXP 6480464 Mechlorethamine results in increased expression of MIR200A mRNA CTD PMID:33971176 melatonin decreases expression EXP 156430315 melatonin decreases expression of Mir200a RNA in pulmonary artery smooth muscle cells RGD methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of MIR200A mRNA, Methapyrilene results in increased expression of MIR200A mRNA alternative form CTD PMID:22363424 , PMID:22584684 methimazole multiple interactions ISO RGD:1607646 6480464 [Methimazole co-treated with Buthionine Sulfoximine] results in increased expression of MIR200A mRNA CTD PMID:27421576 monocrotaline increases expression EXP 156430315 monocrotaline increases expression of Mir200a RNA in pulmonary artery smooth muscle cells RGD monocrotaline multiple interactions EXP 156430315 melatonin inhibits the reaction [monocrotaline increases expression of Mir200a RNA in pulmonary artery smooth muscle cells] RGD N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MIR200A mRNA CTD PMID:30712312 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1348162 6480464 MIR200A mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form] CTD PMID:32016794 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1607646 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of and results in decreased secretion of MIR200A mRNA CTD PMID:32016794 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MIR200A mRNA, Acetaminophen results in increased expression of MIR200A mRNA alternative form CTD PMID:22363424 , PMID:27397436 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of MIR200A mRNA CTD PMID:22584684 , PMID:24157574 rifampicin increases expression ISO RGD:1348162 6480464 Rifampin results in increased expression of MIR200A mRNA CTD PMID:24552687 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MIR200A CTD PMID:32392329 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:1607646 6480464 [Methimazole co-treated with Buthionine Sulfoximine] results in increased expression of MIR200A mRNA CTD PMID:27421576 silver atom increases expression ISO RGD:1348162 6480464 Silver results in increased expression of MIR200A mRNA CTD PMID:26551752 silver(0) increases expression ISO RGD:1348162 6480464 Silver results in increased expression of MIR200A mRNA CTD PMID:26551752 sodium arsenite decreases expression ISO RGD:1348162 6480464 sodium arsenite results in decreased expression of MIR200A mRNA CTD PMID:21292642 sodium arsenite multiple interactions ISO RGD:1607646 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MIR200A mRNA CTD PMID:34952004 sodium arsenite increases methylation ISO RGD:1348162 6480464 sodium arsenite results in increased methylation of MIR200A promoter CTD PMID:21292642 sodium arsenite increases expression ISO RGD:1348162 6480464 sodium arsenite results in increased expression of MIR200A mRNA CTD PMID:27054085 , PMID:34032870 streptozocin increases expression ISO RGD:1607646 6480464 Streptozocin results in increased expression of MIR200A mRNA CTD PMID:27629361 tetrachloromethane multiple interactions ISO RGD:1607646 6480464 CXCL14 mRNA promotes the reaction [Carbon Tetrachloride results in decreased expression of MIR200A mRNA], GPR137B-PS mRNA promotes the reaction [Carbon Tetrachloride results in decreased expression of MIR200A mRNA] CTD PMID:33069761 tetrachloromethane multiple interactions EXP 6480464 Carvedilol inhibits the reaction [Carbon Tetrachloride results in decreased expression of MIR200A mRNA] CTD PMID:30254303 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MIR200A mRNA CTD PMID:30254303 tetrachloromethane decreases expression ISO RGD:1607646 6480464 Carbon Tetrachloride results in decreased expression of MIR200A mRNA CTD PMID:33069761 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MIR200A mRNA CTD PMID:27397436 thioacetamide multiple interactions EXP 6480464 ferulic acid inhibits the reaction [Thioacetamide results in decreased expression of MIR200A mRNA] more ... CTD PMID:32278740 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of MIR200A mRNA CTD PMID:32278740 wortmannin multiple interactions ISO RGD:1348162 6480464 [wortmannin co-treated with Dehydroepiandrosterone] results in increased expression of MIR200A mRNA CTD PMID:25969534 zearalenone multiple interactions ISO RGD:1348162 6480464 Zearalenone results in decreased expression of and affects the secretion of MIR200A mRNA CTD PMID:33419253 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of MIR200A mRNA CTD PMID:22689922 zinc atom decreases expression ISO RGD:1348162 6480464 Zinc deficiency results in decreased expression of MIR200A mRNA CTD PMID:22171008 zinc(0) decreases expression ISO RGD:1348162 6480464 Zinc deficiency results in decreased expression of MIR200A mRNA CTD PMID:22171008 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of MIR200A mRNA CTD PMID:22689922